Cargando…
Dispositions and Causality Assessment in Pharmacovigilance: Proposing the Dx3 Approach for Assessing Causality with Small Data Sets
A new approach is proposed for assessing causality in pharmacovigilance. The Dx3 approach is designed to qualitatively evaluate three types of dispositions when assessing whether a particular medicine has or could have caused a certain adverse event. These are: the drug disposition; the pre-disposit...
Autores principales: | Anjum, Rani Lill, Chandler, Rebecca E, Rocca, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217857/ https://www.ncbi.nlm.nih.gov/pubmed/35486326 http://dx.doi.org/10.1007/s40290-022-00429-9 |
Ejemplares similares
-
Causal Evidence and Dispositions in Medicine and Public Health
por: Rocca, Elena, et al.
Publicado: (2020) -
A Structured Methodology to Assess Safety Signal Strength and Inform Causality Assessment
por: Sullivan, Tim, et al.
Publicado: (2022) -
Causality assessment: A casualty of compensation?
por: Kulkarni, Anuradha, et al.
Publicado: (2013) -
Pharmacovigilance Considerations for Biosimilars in the USA
por: Grampp, Gustavo, et al.
Publicado: (2015) -
“Artificial Intelligence” for Pharmacovigilance: Ready for Prime Time?
por: Ball, Robert, et al.
Publicado: (2022)